Drug Trial Radar · NCT04964479
A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)
Last checked: Nov 19, 2026Latest source record: Aug 20, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
375
Planned (sponsor's estimate)
Start
Aug 6, 2021
Primary completion
Dec 2022
Study completion Mar 2023
Sponsor
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 16, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A clinical study to evaluate the efficacy and safety of TQB2450 injection combined with Anlotinib Hydrochloride capsules versus K drug as a first-line treatment of advanced non-small cell lung cancer.A total of 375 subjects will be enrolled.
Conditions
- Non Small Cell Lung Cancer
Interventions
TQB2450 injectionDrug
1200mg injection once every 3 week
Anlotinib Hydrochloride CapsulesDrug
12mg capsule once daily
Pembrolizumab injectionDrug
200mg injection once every 3 week
PlaceboDrug
Placebo capsule once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease progression-free survival(PFS) evaluated by Independent Review Committee (IRC)Time frame: Baseline to up to two years
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Affiliated Tumor Hospital of Chongqing University
Chongqing, China · Not yet recruiting
Three Gorges Hospital of Chongqing University
Chongqing, China · Not yet recruiting
Southern Hospital of Southern Medical University
Guangzhou, China · Not yet recruiting
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, China · Not yet recruiting
Zhujiang Hospital of Southern Medical University
Guangzhou, China · Not yet recruiting
Zhujiang Hospital of Southern Medical University
Guangzhou, China · Not yet recruiting
The Fifth Central Hospital of Tianjin
Tianjin, China · Not yet recruiting
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
Beijing Chest Hospital, Capital Medical University
Beijing, Beijing Municipality, China · Not yet recruiting
Peking University Third Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China · Not yet recruiting
Affiliated Hospital of Guangdong Medical University
Zhangjiang, Guangdong, China · Recruiting
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China · Not yet recruiting
The Ninth Affiliated People's Hospital of Shanghai Jiao Tong University, School of Medicine
Shanghai, Shanghai Municipality, China · Not yet recruiting
Tianjin Cancer Hospital
Tianjin, Tianjin Municipality, China · Not yet recruiting
General Hospital of Tianjin Medical University
Tianjin, Tianjin Municipality, China · Not yet recruiting
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, China · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.